Vaishali Pharma Announces Share Split and Bonus Issue Amidst Global Expansion

Vaishali Pharma Ltd plans to split its equity shares and issue bonus shares, bolstering growth and shareholder value. The Mumbai-based company also secured 19 new registrations across global markets, projecting an annual revenue increase of Rs 100 million. Sales climbed 34.70% in Q1FY25, reflecting its robust portfolio and strategy.

In a move to reinforce its growth strategy and shareholder value, Mumbai-based Vaishali Pharma Ltd announced plans to split its equity shares and issue bonus shares. The company set October 15, 2024, as the record date for this action, which will see existing shares split into five portions, enhancing liquidity and access.

Vaishali Pharma also revealed it has secured 19 new registrations in regions including Southern Africa and Latin America, which are expected to significantly boost its annual revenue by Rs 100 million. The company, known for a strong portfolio of over 250 formulation brands, continues to make strides in both domestic and international markets.

For the first quarter of FY25, the company reported a 34.70% increase in sales, totaling Rs 18.08 crore, alongside a rise in net profits. Chairman Atul Vasani emphasized the company's commitment to rewarding shareholders and expanding its presence in the global pharmaceutical sector. Established in 1989, Vaishali Pharma remains a dynamic player in the industry.

(With inputs from agencies.)